Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction

Article Urology & Nephrology

Rare and Complex Urology: Clinical Overview of ERN eUROGEN

Loes Oomen et al.

Summary: This study examined the patient population with rare urorectogenital diseases or complex conditions within the ERN eUROGEN network from 2013 to 2019. The results showed an increase in clinical activity, but there were differences in patient numbers among healthcare providers. Improved definitions of diagnostic codes and a better understanding of the data-gathering process are needed to obtain valid patient numbers.

EUROPEAN UROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study

Ioannis Katsoularis et al.

Summary: A study in Sweden found that COVID-19 is a risk factor for deep vein thrombosis, pulmonary embolism, and bleeding. The study used self-controlled case series and matched cohort studies to investigate 1,057,174 individuals who tested positive for SARS-CoV-2 in Sweden.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Article Hematology

ISTH guidelines for antithrombotic treatment in COVID-19

Sam Schulman et al.

Summary: Antithrombotic agents, particularly heparins, are recommended for patients with COVID-19 to reduce thromboembolism risk. The optimal dosing and timing of these treatments, as well as the benefits of other antithrombotic agents, are still unclear. A panel of experts developed 12 recommendations based on high- to moderate-quality evidence, including the use of prophylactic or therapeutic dose heparin for different patient groups. Additional weak recommendations were made for the use of sulodexide, adding antiplatelet agents, and prophylactic rivaroxaban in select patients. Future updates will incorporate new evidence and may modify these recommendations.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Surgery

Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review

Isaac Cheruiyot et al.

Summary: The study revealed that about 4% of critically ill COVID-19 patients experience arterial thrombotic events, with most patients being male, elderly, and having comorbidities. Arterial thrombosis is often symptomatic and can affect multiple arteries. The mortality rate in these patients is approximately 20%. Further investigation into the underlying mechanisms of arterial thrombosis in COVID-19 is needed to identify potential therapeutic targets.

ANNALS OF VASCULAR SURGERY (2021)

添加到收藏夹

Letter Medicine, General & Internal